Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash

By Tami Luhby, CNN (CNN) — Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients. The move is the latest step in drugmakers’ efforts to provide discounts to Americans willing